In patients who develop chronic myelomonocytic leukemia and carry TET2 mutations in CD34+ hematopoietic progenitor cells, the TET2-mutated CD34+ progenitors preferentially develop into myeloid instead of erythroid cells upon differentiation [82]. Here, TET2 is linked to chronic myelomonocytic leukemia.